Kirken RA - Search Results

1

Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.

Tan SH, Dagvadorj A, Shen F, Gu L, Liao Z, Abdulghani J, Zhang Y, Gelmann EP, Zellweger T, Culig Z, Visakorpi T, Bubendorf L, Kirken RA, Karras J, Nevalainen MT. Tan SH, et al. Among authors: kirken ra. Cancer Res. 2008 Jan 1;68(1):236-48. doi: 10.1158/0008-5472.CAN-07-2972. Cancer Res. 2008. PMID: 18172316

2

Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo.

Dagvadorj A, Kirken RA, Leiby B, Karras J, Nevalainen MT. Dagvadorj A, et al. Among authors: kirken ra. Clin Cancer Res. 2008 Mar 1;14(5):1317-24. doi: 10.1158/1078-0432.CCR-07-2024. Clin Cancer Res. 2008. PMID: 18316550 Free article.

3

A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor.

Nagy ZS, Rui H, Stepkowski SM, Karras J, Kirken RA. Nagy ZS, et al. Among authors: kirken ra. J Immunol. 2006 Oct 15;177(8):5032-40. doi: 10.4049/jimmunol.177.8.5032. J Immunol. 2006. PMID: 17015686

4

Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells.

Behbod F, Nagy ZS, Stepkowski SM, Karras J, Johnson CR, Jarvis WD, Kirken RA. Behbod F, et al. Among authors: kirken ra. J Immunol. 2003 Oct 15;171(8):3919-27. doi: 10.4049/jimmunol.171.8.3919. J Immunol. 2003. PMID: 14530308

5

Role of serine phosphorylation of Stat5a in prolactin-stimulated beta-casein gene expression.

Yamashita H, Nevalainen MT, Xu J, LeBaron MJ, Wagner KU, Erwin RA, Harmon JM, Hennighausen L, Kirken RA, Rui H. Yamashita H, et al. Among authors: kirken ra. Mol Cell Endocrinol. 2001 Oct 25;183(1-2):151-63. doi: 10.1016/s0303-7207(01)00546-9. Mol Cell Endocrinol. 2001. PMID: 11604235

6

Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.

Neilson LM, Zhu J, Xie J, Malabarba MG, Sakamoto K, Wagner KU, Kirken RA, Rui H. Neilson LM, et al. Among authors: kirken ra. Mol Endocrinol. 2007 Sep;21(9):2218-32. doi: 10.1210/me.2007-0173. Epub 2007 Jun 5. Mol Endocrinol. 2007. PMID: 17550976

7

STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.

Nagy ZS, LeBaron MJ, Ross JA, Mitra A, Rui H, Kirken RA. Nagy ZS, et al. Among authors: kirken ra. Mol Cancer. 2009 Aug 26;8:67. doi: 10.1186/1476-4598-8-67. Mol Cancer. 2009. PMID: 19709433 Free PMC article.

8

Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation.

Ross JA, Cheng H, Nagy ZS, Frost JA, Kirken RA. Ross JA, et al. Among authors: kirken ra. J Biol Chem. 2010 Feb 5;285(6):3582-3591. doi: 10.1074/jbc.M109.053843. Epub 2009 Nov 18. J Biol Chem. 2010. PMID: 19923221 Free PMC article.

9

Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.

Nagy ZS, Wang Y, Erwin-Cohen RA, Aradi J, Monia B, Wang LH, Stepkowski SM, Rui H, Kirken RA. Nagy ZS, et al. Among authors: kirken ra. J Leukoc Biol. 2002 Oct;72(4):819-28. J Leukoc Biol. 2002. PMID: 12377952

10

Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.

Kirken RA, Erwin RA, Wang L, Wang Y, Rui H, Farrar WL. Kirken RA, et al. J Immunol. 2000 Nov 1;165(9):5097-104. doi: 10.4049/jimmunol.165.9.5097. J Immunol. 2000. PMID: 11046040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters